Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 22 Apr 2022 14:13 CEST |
LYTIX BIOPHARMA AS | Lytix Biopharma – Minutes of Ordinary General Meeting | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 20 Apr 2022 13:08 CEST |
LYTIX BIOPHARMA AS | Lytix Biopharma - Share capital increase from exercise of warrants | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Apr 2022 09:10 CEST |
LYTIX BIOPHARMA AS | Lytix Biopharma: Annual Report for 2021 | 20103010 Biotechnology | Årsrapporter og revisjonsberetninger |
| 05 Apr 2022 13:57 CEST |
LYTIX BIOPHARMA AS | Lytix Biopharma receives milestone payment from Verrica Pharmaceuticals Inc. triggered by first patient dosed with LTX-315 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 15 Mar 2022 06:36 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma - Exercise of warrants | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 11 Mar 2022 08:13 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma to present at the 6th Annual Next Gen Immuno-Oncology Congress, UK | 20103010 Biotechnology | Non-regulatory press releases |
| 17 Feb 2022 07:06 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma fourth quarter 2021 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 15 Feb 2022 17:27 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma granted 3 MNOK from Oslo Regional Research Fund | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 10 Feb 2022 09:22 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma: Presentation of fourth quarter 2021 results, Thursday 17 February | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 10 Feb 2022 09:12 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma: Presentation of fourth quarter 2021 results, Thursday 17 February | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 17 Dec 2021 10:35 CET |
LYTIX BIOPHARMA AS | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 17 Dec 2021 10:35 CET |
LYTIX BIOPHARMA AS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2021 08:00 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma AS Announces that First Patient Started Treatment in the ATLAS-IT-05 clinical trial | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 25 Nov 2021 07:00 CET |
LYTIX BIOPHARMA AS | Lytix Biopharma third quarter 2021 results | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |